-
1.发明公开
公开(公告)号：EP2720684A2
公开(公告)日：2014-04-23
申请号：EP12758603.0
申请日：2012-06-13
申请人： Ipsen Pharma S.a.S.
发明人： RICHARD, Joël , LAREDJ, Faïza , BARONNET, Marie-Madeleine , NOURRISSON, Didier , HARNETT, Jeremiah , HACHER, Béatrice , MONDOLY, Nathalie , BERTOCCHI, Laurent
CPC分类号： A61K9/1652 , A61K9/0019 , A61K38/33
摘要： The present invention relates to a sustained-release drug composition consisting essentially of microparticles of a peptide as the active substance and a biocompatible water-soluble polymer, in particular peptide as meianocortin receptor ligand. The present invention relates also to an injection formulation comprising the sustained-release drug composition suspended in an injection medium.
-
2.发明公开COMPOSITION PHARMACEUTIQUE SOLIDE CONTENANT LE 6-OXO-6,7,8,9,10,11-HEXAHYDROCYCLOHEPTA(C)CHROMEN-3-YL SULFAMATE ET POLYMORPHES DE CE DERNIER 审中-公开WITH -6-氧代6,7,8,9,10,11 - 六氢 - 环庚固体药物组合物（C）苯并吡喃-3-基 - 氨基磺酸酯和多晶型物
公开(公告)号：EP2396311A2
公开(公告)日：2011-12-21
申请号：EP10707096.3
申请日：2010-02-12
申请人： IPSEN PHARMA S.A.S.
发明人： MONDOLY, Nathalie , POIROT, Bertrand , BROCHARD, Anne , RICHARD, Joël , DELAHAYE, Delphine , DIOLEZ, Christian , ROLLAND, Alain , DIANCOURT, Francis , COQUEREL, Gérard , MARTINS, Damien , LINOL, Julie , HOUSSIN, Ophélie , PETIT, Marie-Noêlle , POTTER, Barry, Victor, Lloyd , WOO, Lok, Wai, Lawrence
IPC分类号： C07D311/94 , A61K31/352 , A61K31/353 , C07D311/78 , A61P35/00
CPC分类号： C07D311/78 , A61K9/2018 , A61K9/2054 , A61K9/2059 , A61K9/4858 , A61K31/353 , A61K31/37 , C07D311/94
摘要： The present invention relates to a solid pharmaceutical composition including the active principle 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate. The present invention also relates to polymorphs of the 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate compound.
-
公开(公告)号：EP3810209A1
公开(公告)日：2021-04-28
申请号：EP19730841.4
申请日：2019-06-20
申请人： IPSEN PHARMA S.A.S.
发明人： DELPORTE, Marie , HOVEST, Sabine , KAUFMANN, Jens , MEWIS, Dennis , PETIT, Anne , RICHARD, Joël
-
公开(公告)号：EP2720684B1
公开(公告)日：2019-01-16
申请号：EP12758603.0
申请日：2012-06-13
申请人： IPSEN PHARMA S.A.S.
-
公开(公告)号：EP3027200A1
公开(公告)日：2016-06-08
申请号：EP14747871.3
申请日：2014-07-21
申请人： IPSEN PHARMA S.A.S.
发明人： PETIT, Anne , BARONNET, Marie-Madeleine , RICHARD, Joël , HARNETT, Jeremiah , ARTZNER, Franck , CHERIF-CHEIKH, Roland , PATERNOSTRE, Marie-Thérèse , MONTES, Martin , CARDUS MALESPINA, Mercedes , VALERY, Céline.
CPC分类号： A61K38/09 , A61K9/0019 , A61K9/08 , A61K47/02
摘要： The present invention relates to an aqueous pharmaceutical composition for a sustained release of a LHRH analogue, in particular for a sustained release compatible with therapeutic treatments for at least 2 weeks. The pharmaceutical compositions are particularly useful for the treatment of diseases a LHRH analogue is indicated for.
-
6.发明公开SUSTAINED RELEASE FORMULATIONS COMPRISING GNRH ANALOGUES 有权GNRH-ANALOGA ENTHALTENDE FORMULIERUNGEN MITVERZÖGERTERFREISETZUNG
公开(公告)号：EP2424558A2
公开(公告)日：2012-03-07
申请号：EP10728285.7
申请日：2010-04-29
申请人： IPSEN PHARMA S.A.S.
发明人： CHERIF-CHEIKH, Roland , LACOMBE, Frédéric , TORRES SALGADO, Maria-Luisa , CAMBRIEL, Perrine , CARDUS MALASPINA, Mercè , DIAZ DEL CONSUELO, Isabel , MONTES, Martin , JEANNEROT, Fabien , DELPORTE, Marie , BROCHARD, Anne , RICHARD, Joël
CPC分类号： A61K9/0092 , A61K9/0024 , A61K9/1647 , A61K38/09 , A61K38/24 , A61K47/34 , A61L27/18 , A61L27/50 , A61L27/54 , A61L27/58 , A61L2300/25 , A61L2300/602 , B29C47/0004 , B29K2067/043 , B29K2067/046 , B29K2105/0035 , B29K2105/0085 , B29K2995/006 , B29L2009/005 , C08L67/04
摘要： The present invention relates to pharmaceutical compositions for the controlled and sustained release of active substance comprising a biodegradable polymer or copolymer. Furthermore, the invention relates to pharmaceutical compositions for the controlled and sustained release of at least one active substance such as peptides or hormones and analogues thereof and the manufacturing process of such pharmaceutical compositions.
摘要翻译： 本发明涉及用于控制和持续释放包含可生物降解的聚合物或共聚物的活性物质的药物组合物。 此外，本发明涉及用于控制和持续释放至少一种活性物质如肽或激素及其类似物的药物组合物和这种药物组合物的制造方法。
-
公开(公告)号：EP3035912A1
公开(公告)日：2016-06-29
申请号：EP14736812.0
申请日：2014-07-08
申请人： IPSEN PHARMA S.A.S.
发明人： BIELSA GUIVERNAU, Ruth , CHERIF-CHEIKH, Roland , FOURNES, Julie , MARTINEZ LORENTE, Daniel , PETIT, Anne , RICHARD, Joël
CPC分类号： A61K38/08 , A61K9/0019 , A61K9/0024 , A61K38/31 , A61K47/10 , A61K47/12 , A61K47/22
摘要： The present invention relates to a pharmaceutical composition for a sustained release of lanreotide, in particular for a sustained release compatible with therapeutic treatments for at least 2 months. The pharmaceutical compositions are particularly useful for the treatment of diseases lanreotide is indicated for.
-
公开(公告)号：EP2501367B1
公开(公告)日：2015-01-21
申请号：EP10784450.8
申请日：2010-11-17
申请人： IPSEN PHARMA S.A.S.
发明人： GOPINATH, Enona , PARK, Susan , ARAKAWA, Tsutomu , RICHARD, Joël , FAIS, Fabio
CPC分类号： A61K47/183 , A61K9/0019 , A61K9/19 , A61K38/27 , A61K38/30 , A61K47/02 , A61K47/10 , A61K47/26 , A61K2300/00
摘要： The present invention relates to pharmaceutical compositions. More particularly, the invention relates to formulations of growth hormone (GH) and insulin-like growth factor (IGF-1) combination compositions which provide stable pharmaceutical compositions without aggregation formation at a desirable pH, and to processes of preparation thereof.
摘要翻译： 药物组合物，特别是包含在没有聚集形成的期望pH下稳定的生长激素（GH）和胰岛素样生长因子（IGF-1）的组合物，以及制备该组合物的方法。
-
公开(公告)号：EP2501367A1
公开(公告)日：2012-09-26
申请号：EP10784450.8
申请日：2010-11-17
申请人： IPSEN PHARMA S.A.S.
发明人： GOPINATH, Enona , PARK, Susan , ARAKAWA, Tsutomu , RICHARD, Joël , FAIS, Fabio
CPC分类号： A61K47/183 , A61K9/0019 , A61K9/19 , A61K38/27 , A61K38/30 , A61K47/02 , A61K47/10 , A61K47/26 , A61K2300/00
摘要： The present invention relates to pharmaceutical compositions. More particularly, the invention relates to formulations of growth hormone (GH) and insulin-like growth factor (IGF-1) combination compositions which provide stable pharmaceutical compositions without aggregation formation at a desirable pH, and to processes of preparation thereof.
-
公开(公告)号：EP3810208A1
公开(公告)日：2021-04-28
申请号：EP19730839.8
申请日：2019-06-20
申请人： IPSEN PHARMA S.A.S.
-
-
-
-
-
-
-
-
-
搜索结果
11 条记录 (耗时 0.012 秒)
